Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension
- PMID: 20724703
- DOI: 10.1161/CIRCRESAHA.110.222794
Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension
Abstract
Rationale: Bone morphogenic protein (BMP)4 can stimulate superoxide production and exert proinflammatory effects on the endothelium. The underlying mechanisms of how BMP4 mediates endothelial dysfunction and hypertension remain elusive.
Objective: To elucidate the cellular pathways by which BMP4-induced endothelial dysfunction is mediated through oxidative stress-dependent upregulation of cyclooxygenase (COX)-2.
Methods and results: Impaired endothelium-dependent relaxations, exaggerated endothelium-dependent contractions, and reactive oxygen species (ROS) production were observed in BMP4-treated mouse aortae, which were prevented by the BMP4 antagonist noggin. Pharmacological inhibition with thromboxane prostanoid receptor antagonist or COX-2 but not COX-1 inhibitor prevented BMP4-induced endothelial dysfunction, which was further confirmed with the use of COX-1(-/-) or COX-2(-/-) mice. Noggin and knockdown of BMP receptor 1A abolished endothelium-dependent contractions and COX-2 upregulation in BMP4-treated aortae. Apocynin and tempol treatment were effective in restoring endothelium-dependent relaxations, preventing endothelium-dependent contractions and eliminating ROS overproduction and COX-2 overexpression in BMP4-treated aortae. BMP4 increased p38 mitogen-activated protein kinase (MAPK) activity through a ROS-sensitive mechanism and p38 MAPK inhibitor prevented BMP4-induced endothelial dysfunction. COX-2 inhibition blocked the effect of BMP4 without affecting BMP4-induced ROS overproduction and COX-2 upregulation. Importantly, renal arteries from hypertensive rats and humans showed higher levels of COX-2 and BMP4 accompanied by endothelial dysfunction.
Conclusions: We show for the first time that ROS serve as a pathological link between BMP4 stimulation and the downstream COX-2 upregulation in endothelial cells, leading to endothelial dysfunction through ROS-dependent p38 MAPK activation. This BMP4/ROS/COX-2 cascade is important in the maintenance of endothelial dysfunction in hypertension.
Similar articles
-
Inhibition of bone morphogenic protein 4 restores endothelial function in db/db diabetic mice.Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):152-9. doi: 10.1161/ATVBAHA.113.302696. Epub 2013 Nov 7. Arterioscler Thromb Vasc Biol. 2014. PMID: 24202302
-
Bone morphogenic protein-4 induces endothelial cell apoptosis through oxidative stress-dependent p38MAPK and JNK pathway.J Mol Cell Cardiol. 2012 Jan;52(1):237-44. doi: 10.1016/j.yjmcc.2011.10.013. Epub 2011 Oct 25. J Mol Cell Cardiol. 2012. PMID: 22064324
-
Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation.Circulation. 2006 Jun 20;113(24):2818-25. doi: 10.1161/CIRCULATIONAHA.106.611822. Epub 2006 Jun 12. Circulation. 2006. PMID: 16769910
-
Endothelial dysfunction in diabetes and hypertension: cross talk in RAS, BMP4, and ROS-dependent COX-2-derived prostanoids.J Cardiovasc Pharmacol. 2013 Mar;61(3):204-14. doi: 10.1097/FJC.0b013e31827fe46e. J Cardiovasc Pharmacol. 2013. PMID: 23232839 Review.
-
Redox signaling in hypertension.Cardiovasc Res. 2006 Jul 15;71(2):247-58. doi: 10.1016/j.cardiores.2006.05.001. Epub 2006 May 9. Cardiovasc Res. 2006. PMID: 16765337 Review.
Cited by
-
Expression pattern of the bone morphogenetic protein-4 and its relationship with inflammation, vascular injury in patients suffered the arterial occlusive diseases.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Feb 28;49(2):279-285. doi: 10.11817/j.issn.1672-7347.2024.230264. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 38755724 Free PMC article. Chinese, English.
-
Protective potential of naringenin and its nanoformulations in redox mechanisms of injury and disease.Heliyon. 2023 Nov 25;9(12):e22820. doi: 10.1016/j.heliyon.2023.e22820. eCollection 2023 Dec. Heliyon. 2023. PMID: 38058425 Free PMC article. Review.
-
The Mechanism of Mori Folium and Eucommiae Cortex against Cyclophosphamide-Induced Immunosuppression Integrating Network Pharmacology, Molecular Docking, Molecular Dynamics Simulations, and Experimental Validation.Metabolites. 2023 Nov 15;13(11):1151. doi: 10.3390/metabo13111151. Metabolites. 2023. PMID: 37999247 Free PMC article.
-
Insights into bone morphogenetic proteins in cardiovascular diseases.Front Pharmacol. 2023 Feb 23;14:1125642. doi: 10.3389/fphar.2023.1125642. eCollection 2023. Front Pharmacol. 2023. PMID: 36909186 Free PMC article. Review.
-
Infiltrating circulating monocytes provide an important source of BMP4 at the early stage of spinal cord injury.Dis Model Mech. 2023 Jan 1;16(1):dmm049856. doi: 10.1242/dmm.049856. Epub 2023 Jan 18. Dis Model Mech. 2023. PMID: 36518009 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials